MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.500
+0.010
+0.67%
After Hours: 1.500 0 0.01% 16:44 07/07 EDT
OPEN
1.510
PREV CLOSE
1.490
HIGH
1.520
LOW
1.420
VOLUME
4.72M
TURNOVER
--
52 WEEK HIGH
2.725
52 WEEK LOW
0.9085
MARKET CAP
507.78M
P/E (TTM)
-6.4739
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OCGN last week (0629-0703)?
Weekly Report · 1d ago
Largest borrow rate increases among liquid names
TipRanks · 5d ago
Ocugen to present modifier gene therapy platform at Piper Sandler Virtual Ophthalmology Day
PUBT · 6d ago
Ocugen Inc. Stock Climbs 11.3%, Outperforms Market
Dow Jones · 06/29 20:32
Weekly Report: what happened at OCGN last week (0622-0626)?
Weekly Report · 06/29 09:34
Ocugen Inc. Stock Climbs 9.5%, Outperforms Market
Dow Jones · 06/26 20:32
Ocugen: Financing Risk Is Lower, But The Clinical Bet Still Has To Work
Seeking Alpha · 06/25 04:35
Ocugen Inc. Stock Climbs 7.0%, Outperforms Market
Dow Jones · 06/23 20:35
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Novel Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.